Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA), shared a post on X:
“FDA is moving with unprecedented agility.
Today we approved a multiple myeloma drug just 55 days after the application was filed. And last week’s approval (a major leap forward) was approved in 44 days.
If a trial result shows immediate promise for many Americans, why wait?”
Proceed to the video attached to the post.
Other articles featuring Marty Makary on OncoDaily.